Advancements in Healthcare Technologies and Investment Strategies

The chapter delves into the evolution of healthcare technologies, from the development of the COVID vaccine to the current focus on targeting DNA using advanced technologies like mRNA, gene therapy, and CRISPR. It explores the potential of new treatment modalities, such as bispecific antibodies and targeted small molecules, to revolutionize disease treatment in the coming years. Additionally, the discussion covers Wellington's significant investments in alternative assets like private equity and venture capital, with a particular focus on the trend of companies, especially in the biotechnology sector, choosing to remain private longer.